Kineta
Kineta is a Washington-based clinical-stage biotechnology company that researches and develops novel immunotherapies for the treatment of cancer.
Business Model:
Revenue: $4.8M
Employees: 11-50
Industries / Tags:
Detailed Kineta Information
Geographic Data
Address: 219 Terry Avenue North
City: Seattle
State: WA
Zip: 98109
Country: US
Financial Info
Stage:
corporate round
Raised Last:
$17M
Raised Total:$81M
Social
Metrics
3,133,510Website Global Rank
5,261Website Monthly Traffic
Twitter Followers
Description
Kineta is a Washington-based clinical-stage biotechnology company that researches and develops novel immunotherapies for the treatment of cancer.
Contact Phone:
+12063780400
Contact Email:
Kineta went public on the NASDAQ
Listed Exchange:
NASDAQ
Ticker Symbol:
KA
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2022 | Debt | $2.4M |
Hall Capital RLB Holdings, LLC Swan Venture Group |
5/2021 | Corporate Round | $10M |
Cheongbo Industrial Co |
6/2021 | Equity | $1.2M |
swan venture |
12/2022 | PIPE | $7.5M | 12/2022 | IPO | - | 1/2015 | Series B | 1 | $7M |
Keiretsu Capital Keiretsu Capital |
7/2016 | Venture Round | 1 | $1.5M |
Puget Sound Venture Club National Institute of Allergy and Infectious Diseases Puget Sound Venture Club |
5/2015 | Venture Round | 1 | - |
Keiretsu Forum Northwest Keiretsu Forum Northwest |
5/2020 | Venture Round | 1 | $5M |
SCHLAEPFER FAMILY FOUNDATION SCHLAEPFER FAMILY FOUNDATION |
7/2010 | Venture Round | $709.3k | 10/2013 | Venture Round | 1 | $760.5k |
RJ Jones RJ Jones |
10/2017 | Venture Round | $24.4M | 5/2016 | Venture Round | $760.8k | 8/2012 | Venture Round | $5.8M | 1/2010 | Venture Round | $942.5k | 6/2021 | Corporate Round | 1 | $17.4M |
Cheongbo Industrial Co. (CBI) Cheongbo Industrial Co. (CBI) |
5/2014 | Venture Round | $1.6M | 3/2014 | Venture Round | 1 | - |
AngelMD AngelMD |
6/2016 | Debt Financing | $1.8M | 9/2017 | Debt Financing | - | 8/2019 | Grant | 1 | $1.8M |
Wellcome Trust Wellcome Trust Wellcome Trust |
7/2016 | Grant | 1 | $1.5M |
National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases |
9/2018 | Venture Round | 1 | $7.1M |
Keiretsu Forum Keiretsu Forum |
9/2017 | Venture Round | $5M | 12/2022 | Post-IPO Equity | $7.5M | 5/2019 | Venture Round | 1 | $45k |
SFC Capital SFC Capital SFC Capital SFC Capital |
12/2022 | IPO | - |
|
9/2017 | Debt Financing | - |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
